Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
1.
Ter Arkh ; 56(11): 58-64, 1984.
Artigo em Russo | MEDLINE | ID: mdl-6523390

RESUMO

Investigations made by the authors permit the conclusion that in order to correct the disturbed amino acid content of the gastric mucosa and blood serum, mirroring the trends in the catabolic processes occurring in the body and disorder of liver amino acid-forming function, it is necessary to include the drugs eliminating the causes of the disorders (e. g. neurogenic dystrophy), stimulants of protein synthesis and amino acid preparations as structural material for proteins into the complex of treatment measures.


Assuntos
Aminoácidos/metabolismo , Mucosa Gástrica/metabolismo , Úlcera Péptica/metabolismo , Aminoácidos/deficiência , Atropina/administração & dosagem , Quimioterapia Combinada , Compostos de Hexametônio/administração & dosagem , Humanos , Nandrolona/administração & dosagem , Nandrolona/análogos & derivados , Decanoato de Nandrolona , Papaverina/administração & dosagem , Úlcera Péptica/tratamento farmacológico
2.
Ter Arkh ; 56(8): 100-6, 1984.
Artigo em Russo | MEDLINE | ID: mdl-6495187

RESUMO

It has been demonstrated that peptic ulcer patients manifest hypo- and dysaminoacidemia and a dramatic increase in the amino acid pool of the gastric mucosa which are accounted for by neurogenic dystrophy leading to catabolic orientation of the processes not only in the mucous membrane of the gastroduodenal zone but also in other organs with a high level of protein synthesis, particularly in the liver. Based on the coefficients that determine amino acid transformation in the liver and analysis of the blood serum content of replaceable amino acids, peptic ulcer patients were discovered to have marked impairment of the amino acid-forming function of the liver.


Assuntos
Aminoácidos/metabolismo , Mucosa Gástrica/metabolismo , Úlcera Péptica/metabolismo , Aminoácidos/biossíntese , Aminoácidos/sangue , Humanos , Fígado/metabolismo , Úlcera Péptica/sangue
3.
Klin Med (Mosk) ; 69(7): 38-42, 1991 Jul.
Artigo em Russo | MEDLINE | ID: mdl-1942971

RESUMO

The study of 468 ulcer patients treated by laser irradiation plus choline blocking agents with adjuvant alpha-tocopherol antioxidants (alpha-tocopherol acetate, wild rose and sea-buckthorn oils) provided evidence in favour of the antioxidants addition. Combination of hyperbaric oxygenation (5-6 sessions) or riboxin with choline blocking agents made antioxidants unnecessary. Biochemical findings (vitamin E and malonic dialdehyde concentrations), electron microscopic, ++histo-enzyme and amino acids studies supported the clinical evidence.


Assuntos
Oxigenoterapia Hiperbárica , Terapia a Laser , Peroxidação de Lipídeos/fisiologia , Parassimpatolíticos/administração & dosagem , Úlcera Péptica/metabolismo , Deficiência de Vitamina E/etiologia , Vitamina E/sangue , Antioxidantes , Terapia Combinada , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos da radiação , Úlcera Péptica/complicações , Úlcera Péptica/terapia , Vitamina E/administração & dosagem , Deficiência de Vitamina E/tratamento farmacológico
4.
Lik Sprava ; (9): 76-80, 1992 Sep.
Artigo em Russo | MEDLINE | ID: mdl-1481513

RESUMO

Use of treatment complexes including non-drug methods (auricular acupuncture, pathogenetic dietotherapy, ILBR) or reduced doses of modern pharmacopreparations allowed to achieve rapid clinical and endoscopic remission in patients with ulcer disease. Simultaneously occurs normalization of the aggressive and defensive properties of the gastric juice, immunological, microcirculatory changes in the body and gastroduodenal mucosa. The vascular laser blood radiation reduced antacid dose and pathogenetic dietotherapy.


Assuntos
Úlcera Duodenal/reabilitação , Biópsia , Doença Crônica , Terapia Combinada/métodos , Úlcera Duodenal/fisiopatologia , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patologia , Humanos , Modalidades de Fisioterapia/métodos , Indução de Remissão
5.
Lik Sprava ; (3-4): 56-60, 1996.
Artigo em Russo | MEDLINE | ID: mdl-9035882

RESUMO

Investigations designed to study gastric mucosa (GM) in patients with chronic primary gastroduodenitis with the aid of electron microscopy showed the abnormal changes in the cellular, subcellular membranes and capillaries to be of the same type as they are in peptic ulcer (PU) though poorly manifest. Changes in GM under chronic atrophic gastroduodenitis (ChGD) suggested involutive changes while in chronic secondary gastroduodenitis (ChSGD) it was generally not different from the mucosa ultrastructure in healthy subjects except for changes in surface epithelium. Based on the histoenzymologic studies it has been ascertained that in ChPGD there occurs a rise in lysosomal enzymes similar to that encountered in PU, reflecting the intensity of catabolic processes, decrease in the activity of enzymes of the capillary wall and mitochondria respiratory chain against the background of compensatory enhancement of the activity of the glycolytic enzyme lactate dehydrogenase. In ChAGD the activity of all the enzymes was low, while in ChSGD it did not differ significantly from that in healthy subjects.


Assuntos
Duodenite/enzimologia , Duodenite/patologia , Mucosa Gástrica/enzimologia , Mucosa Gástrica/ultraestrutura , Gastrite/enzimologia , Gastrite/patologia , Doença Crônica , Mucosa Gástrica/metabolismo , Humanos , Microscopia Eletrônica
6.
Lik Sprava ; (5-6): 87-91, 1995.
Artigo em Russo | MEDLINE | ID: mdl-8630823

RESUMO

Tardipherone is capable of maximum absorption in the initial portion of small intestine, iron being in its retarding form, which fact ensures a prolonged action of the drug, mucoprotease being a part of tardipherone composition acting to guard gastric and duodenal mucosae against irritating effect of iron. Tardipherone was found to be efficacious in treating patients with ulcer disease complicated by bleeding. Under its effect the hemogram indices get normalized as does the ratio of aggressive to protective factors of gastric juice, which factors play a major part in the emergent relapse of the illness. The use of tardipherone was found to be justified in the treatment of patients with chronic atrophic gastritis, being associated with gratifying shifts in the clinical picture of the condition and improvement in the hemogram characteristics.


Assuntos
Úlcera Duodenal/complicações , Compostos Ferrosos/uso terapêutico , Gastrite Atrófica/tratamento farmacológico , Mucinas/uso terapêutico , Úlcera Péptica Hemorrágica/tratamento farmacológico , Úlcera Gástrica/complicações , Adulto , Anemia Ferropriva/sangue , Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/etiologia , Preparações de Ação Retardada , Combinação de Medicamentos , Avaliação de Medicamentos , Quimioterapia Combinada , Feminino , Gastrite Atrófica/sangue , Gastrite Atrófica/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Úlcera Péptica Hemorrágica/sangue , Úlcera Péptica Hemorrágica/complicações , Indução de Remissão
7.
Lik Sprava ; (7-8): 84-7, 1995.
Artigo em Russo | MEDLINE | ID: mdl-8846383

RESUMO

A peroral sugar-reducing preparation gliquidone (glurenorm) was tried in treatment of 66 patients with digestive diseases (peptic ulcer, chronic pancreatitis, cirrhosis of the liver), presenting with diabetes mellitus. The results of the studies made showed glurenorm to be a highly effective preparation in term of both its sugar-reducing effect and its capability to improve energy processes in gastric and duodenal mucosa, pancreacytes, hepatocytes, besides which, it appear to dispel metabolic disturbances and stimulate reparative processes in body organs, improves protein-synthetic processes in the liver, pancreas, mucosa of the gastroduodenal region.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Doenças do Sistema Digestório/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Compostos de Sulfonilureia/uso terapêutico , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Doenças do Sistema Digestório/sangue , Doenças do Sistema Digestório/complicações , Avaliação de Medicamentos , Quimioterapia Combinada , Suco Gástrico/efeitos dos fármacos , Humanos , Hipoglicemiantes/efeitos adversos , Indução de Remissão , Compostos de Sulfonilureia/efeitos adversos , Fatores de Tempo
9.
Lik Sprava ; (5-6): 119-22, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7831874

RESUMO

In the present investigation on the treatment of patients with nonulcerous dyspepsia and peptic ulcer, hiatus hernia complicated with reflux esophagitis, a mechanism has been studied of the action of topalkan, a 3rd generation aluminium-magnesium antacid, that involves not only its antacid properties but in an even greater degree the availability of alginic acid in its formula which has antipeptic and protective effect with respect of the mucous membrane of the stomach and esophagus, and provides, together with the magnesium salts, a floating layer of the preparation in the stomach. In grave course of nonulcerous dyspepsia (preulcerous condition) and peptic ulcer complicated by reflux disease of the esophagus topalkan was used in combination with present-day antisecretory preparations pyrenzepine or H2-blockaders of histamine receptors capable of enhancing the antisecretory effect of topalkan as well as endowed with cytoprotective properties with respect of the mucous membrane of the stomach and duodenum promoting healing of erosions and healing and scarring of ulcerous defects.


Assuntos
Antiácidos/uso terapêutico , Úlcera Duodenal/tratamento farmacológico , Dispepsia/tratamento farmacológico , Esofagite Péptica/tratamento farmacológico , Hidróxido de Alumínio , Antiácidos/farmacologia , Combinação de Medicamentos , Avaliação de Medicamentos , Quimioterapia Combinada , Úlcera Duodenal/complicações , Esofagite Péptica/etiologia , Determinação da Acidez Gástrica , Hérnia Hiatal/complicações , Hérnia Hiatal/tratamento farmacológico , Humanos , Concentração de Íons de Hidrogênio , Hidróxido de Magnésio , Comprimidos , Fatores de Tempo
10.
Lik Sprava ; (7-8): 117-20, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7900331

RESUMO

Effectiveness of the use of Omeprazolum (Oside) was studied in 24 patients with ulcer disease, 16 patients with chronic primary gastroduodenitis and 18 patients with acid reflux-esophagitis. The preparation Oside is a highly effective agent for the treatment of the aforementioned conditions and possesses a powerful antisecretory and antioxidant activity. Against the background of the use of the preparation the count of Helicobacter pylori gets decreased in the antral part of the stomach. The use of the preparation is not accompanied by side-effects and it does not have reverse acidic effect, in which respect has been shown to be superior to H2-histamine blockers.


Assuntos
Doenças do Sistema Digestório/tratamento farmacológico , Omeprazol/uso terapêutico , Avaliação de Medicamentos , Duodenite/tratamento farmacológico , Dispepsia/tratamento farmacológico , Esofagite Péptica/tratamento farmacológico , Gastrite/tratamento farmacológico , Humanos , Omeprazol/efeitos adversos , Úlcera Péptica/tratamento farmacológico , Indução de Remissão
11.
Lik Sprava ; (1): 66-8, 1992 Jan.
Artigo em Russo | MEDLINE | ID: mdl-1364612

RESUMO

Intravascular laser radiation of the blood was employed in 68 patients with ulcer disease in the complex treatment with antacid; cholinolytic, antioxidant agents. The employment of helium-neon laser as an immunomodulator resulted in an improvement of indices of cellular and humoral immunity, normalization of lipid peroxidation, increased resistance of the gastric and duodenal mucosa, reduction of the time of scarring of the ulcer defect against the background of rapid clinical remission, increase of the interrecurrence period.


Assuntos
Sangue/efeitos da radiação , Terapia a Laser , Úlcera Péptica/radioterapia , Adulto , Formação de Anticorpos/efeitos da radiação , Feminino , Humanos , Imunidade Celular/efeitos da radiação , Peroxidação de Lipídeos/efeitos da radiação , Masculino , Pessoa de Meia-Idade , Úlcera Péptica/sangue , Úlcera Péptica/imunologia
12.
Lik Sprava ; (3-4): 61-4, 1995.
Artigo em Russo | MEDLINE | ID: mdl-8819924

RESUMO

Based on the studies made in 84 patients with calculous cholecystitis and 12 patients with calcifying pancreatitis, an efficiency was shown of infusional administration of pyrencepine or ranitidine to prevent stress postoperative erosive-and-ulcerous lesions of gastroduodenal zone. Gastrocepine is shown to be superior to ranitidine and can be withdrawn without a maintenance dose, as well as becouse its cytoprotective effects with respect of the gastric and duodenal mucosa.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios/efeitos adversos , Úlcera Duodenal/prevenção & controle , Complicações Pós-Operatórias/prevenção & controle , Úlcera Gástrica/prevenção & controle , Estresse Fisiológico/complicações , Antiulcerosos/uso terapêutico , Colecistectomia , Avaliação de Medicamentos , Úlcera Duodenal/etiologia , Determinação da Acidez Gástrica , Humanos , Concentração de Íons de Hidrogênio , Pancreatectomia , Pirenzepina/uso terapêutico , Complicações Pós-Operatórias/etiologia , Ranitidina/uso terapêutico , Esteroides , Úlcera Gástrica/etiologia
13.
Lik Sprava ; (9-12): 88-92, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7604597

RESUMO

The indices for the gastric contents aggression and protection ratio returned to normal in patients with peptic ulcer and preulcerous condition during the treatment with smekta due to a decrease in proteolytic activity and increase in the synthesis of the mucus protective proteins. Monitoring of intragastric pH in the body of the stomach throughout 24 hours in patients with peptic ulcer of duodenal location revealed significant acid-neutralizing effect of smekta. Patients with nonspecific ulcerous colitis enjoyed freedom of side effects as a result of the use of salofalk and derived full therapeutic benefit from this treatment. Under the effect of smekta there occurred suppression of the growth of pathogenic proteolytic flora, improvement of qualitative properties of coli flora and growth of sugar-lytic flora in patients with intestinal dysbiosis. According to the data available, smekta strengthens the mucous barrier by improving the conformation of the mucus structural elements.


Assuntos
Doenças do Sistema Digestório/tratamento farmacológico , Silicatos/uso terapêutico , Ácidos Aminossalicílicos/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/uso terapêutico , Doenças do Sistema Digestório/fisiopatologia , Avaliação de Medicamentos , Quimioterapia Combinada , Determinação da Acidez Gástrica , Suco Gástrico/efeitos dos fármacos , Humanos , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/enzimologia , Masculino , Mesalamina , Omeprazol/uso terapêutico , Ratos , Ratos Wistar , Silicatos/farmacologia , ATPase Trocadora de Sódio-Potássio/efeitos dos fármacos , ATPase Trocadora de Sódio-Potássio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA